Cellectar Biosciences, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cellectar Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-09-30 was $0.00.
- Cellectar Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-06-30 was $0.00.
- Cellectar Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-03-31 was $0.00.
- Cellectar Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2017-03-31 was $0.00.
- Cellectar Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $0.00.
- Cellectar Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $0.00.
- Cellectar Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $0.00.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-11-13 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-11-13 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-11-13 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-21 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |